Midd Training Module 4 Case

Media Summary: Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ... This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ...

Midd Training Module 4 Case - Detailed Analysis & Overview

Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ... This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ... Jeffrey Barrett from the Critical Path Institute provides the overview of this This lecture by Dr. S.Y. Amy Cheung, a Senior Director of Integrated Drug Development at Certara, discusses how top-down and ... Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses model interconnectedness and how ...

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and simulation in ... Dr. Hoai-Thu Thai with Sanofi explains how This lecture by Jeffrey Barrett from the Critical Path Institute describes the Medication Management in Patients with Advanced Illnesses: Dr. Jeff Barrett from the Critical path Institute describes the application of

Photo Gallery

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond

MIDD Training OVERVIEW

Module 4 Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen

MIDD Training Module 1

Introduction to the MIDD Training Course

Module 4

View Detailed Profile

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

MIDD Training Module 4 – Case Study 2: Anti-Viral Kinetic Modeling

This lecture by Dr. Rajesh Krishna is a

MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development

MIDD Training Module 4 – Case Study 1: Decision Analysis to Support Drug Development

Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development.

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ...

Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond

Module 4 – Case Study 4: Vaccine PKPD, MBMA, and Beyond

This lecture by Dr. S.Y. Amy Cheung, a senior director of Integrated Drug Development at Certara, aligns the challenges of ...

MIDD Training OVERVIEW

MIDD Training OVERVIEW

Jeffrey Barrett from the Critical Path Institute provides the overview of this

Module 4 Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches

Module 4 Case Study 3 Pediatric Drug Development, Utilization of Top-Down and Bottom-Up Approaches

This lecture by Dr. S.Y. Amy Cheung, a Senior Director of Integrated Drug Development at Certara, discusses how top-down and ...

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Module 4 – Case Study 5 Pharmacometrics & QSP-Based Analysis to Guide GnRH Receptor Modulator Dev’t.

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses model interconnectedness and how ...

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

Module 4 - Case Study 6: Role of Modeling & Simulation in the Development of Pembrolizumab

Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and simulation in ...

Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen

Module 7 – Case Study 4: MIDD to Establish Isatuximab Combination Dosing Regimen

Dr. Hoai-Thu Thai with Sanofi explains how

MIDD Training Module 1

MIDD Training Module 1

This lecture by Jeffrey Barrett from the Critical Path Institute describes the

Introduction to the MIDD Training Course

Introduction to the MIDD Training Course

Dr. Qi Liu, the Assoc. Director

Module 4

Module 4

Medication Management in Patients with Advanced Illnesses:

MIDD Training Module 3 – Pediatric Drug Development Considerations

MIDD Training Module 3 – Pediatric Drug Development Considerations

Dr. Jeff Barrett from the Critical path Institute describes the application of